| Value | ₹759.0 Cr |
|---|
BSE filing, NSE: DDEVPLSTIK. Summary written from the filing by ALFA Finder's alert engine.
Ddev Plastiks Industries Ltd: key numbers
- Share price
- ₹246.26
- Market cap
- ₹2,548 Cr
- Revenue (annual)
- ₹2,948 Cr
- Net profit (annual)
- ₹201.8 Cr
- P/E (TTM)
- 11.9×Sector 52.8×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 1.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ddev Plastiks Industries Ltd
All →Ddev Plastiks Industries Annual General Meeting
Ddev Plastiks Industries has filed the minutes of its 6th Annual General Meeting held on 26 September 2026 through video conferencing. The filing is the minutes of an AGM with no monetary decision.
Ddev Plastiks Industries Other Announcement
The Company has submitted its shareholding pattern for the quarter ended September 30, 2026, as required under Regulation 31(1)(b) of the SEBI Listing Regulations.
Ddev Plastiks Industries Dividend
Ddev Plastiks Industries approved a final dividend of ₹1.25 per equity share for the financial year ended March 31, 2026, payable by October 25, 2026.
Ddev Plastiks Industries Management Change
DDEV Plastiks Industries re-appointed Mrs. Rajni Mishra as Non-Executive Independent Director and M/s B. Mukherjee & Co. as Statutory Auditor for a 5-year term.
Ddev Plastiks Industries Annual General Meeting
Ddev Plastiks Industries held its 6th Annual General Meeting on 26th September 2026 via video conferencing to transact ordinary and special business items.
Ddev Plastiks Industries Annual Report
Ddev Plastiks Industries Limited submitted its Annual Report for the financial year 2025-26 along with the notice for its 6th Annual General Meeting.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.